See all

2021 Updates: Lilly's Global COVID-19 Response

View Story

Living With Osteoarthritis: The Importance of Being Heard

View Story

Your COVID-19 Treatment Journey: Our Antibodies Might Help

View Story

Consent forms for Jonee Drake (Lilly employee) and son Carter are located in CAR.

'A Day On – Not a Day Off': Honoring Dr. Martin Luther King Jr.’s Legacy

View Story

2020 Updates: Lilly's Global COVID-19 Response

View Story

Time to Tear Down the Rebate Wall

View Story

Press Releases

See all

Lilly Completes Acquisition of Prevail Therapeutics

January 22, 2021

Tags |  Corporate

INDIANAPOLIS , Jan. 22, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality for drug discovery and development at Lilly , extending Lilly 's

Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents

January 21, 2021

Tags |  Product

INDIANAPOLIS , Jan. 21, 2021 /PRNewswire/ -- Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, Eli Lilly and Company (NYSE: LLY) announced. The Phase 3 BLAZE-2 COVID-19 prevention trial – conducted in

Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies

January 19, 2021

Tags |  Corporate

INDIANAPOLIS and UTRECHT, The Netherlands , Jan. 19, 2021 /PRNewswire/ -- Loxo Oncology at Lilly , a research and development group of Eli Lilly and Company (NYSE: LLY), and Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology company developing multi-specific antibodies, today announced a research

Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement

January 15, 2021

Tags |  Financial

INDIANAPOLIS , Jan. 15, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the